A new medicine for Alzheimer's disease?Last updated: 05 March 2021You can legally access new medicines, even if they are not approved in your country. Learn how Introducing a breakthrough known as 'CT1812' Just last week, a substance being developed for Alzheimer’s disease known as “CT...
Reports that teams in Boston, Massachusetts and Seattle, Washington identified a third crucial gene in researching Alzheimer's disease. How the picture of the mechanisms of the disease is now largely complete; The teams' research; How their research should help illuminate all types of the disease...
The pharmaceutical industry's drug pipeline has been littered for years with failed Alzheimer's treatments, representing billions in research costs. The FDA's greenlight is likely to revive investments in similar therapies previously shelved by drugmakers. The new medicine is made from living cells t...
| 阿尔茨海默病(AD)从无症状阶段缓慢发展为完全表现的临床综合征需要多年的时间。近日,首都医科大学贾建平团队在国际知名医学期刊NEW ENGLAND JOURNAL OF MEDICINE(IF=159)在线发表题为“Biomarker Changes during 20 Years Preceding Alzheimer’s Disease”的研究论文,该研究该研究检查了来自中国认知与老化研究(COAST)...
#今日行业热点#①The New England Journal of Medicine:A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia 新型CD38单抗治疗免疫性血小板减少症 DOI: 10.1056/NEJMoa2400409 ②The New England Journal of Medicine:APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease ...
The anti-amyloid drugs like lecanemab have created a polarized environment in medicine between those who think the drugs are a dangerous waste of money and those who believe they are a brilliant first step to a cure, said ICER's Rind, who thinks lecanemab has modest benefits. ...
The public health burden of Alzheimer disease (AD), the most common neurodegenerative disease, threatens to explode in the middle of this century. Current
③The New England Journal of Medicine:Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity 临床试验:司美格鲁肽在射血分数保留的心力衰竭合并肥胖患者中的随机、对照试验 DOI: 10.1056/NEJMoa2306963 ④Genome Medicine:Spatial transcriptomics analysis of neoadjuvant cabozantinib ...
The formation of neurofibrillary tangles (NFTs), oxidative stress and neuroinflammation have emerged as key targets for the treatment of Alzheimer’s disease (AD), the most prevalent neurodegenerative disorder. These pathological hallmarks are closely re
Amyloid imaging in Alzheimer’s disease: a potential new era of personalized medicine? Pertussis vaccine-induced experimental autoimmune encephalomyelitis in mice Cognitive emotion regulation and stress: a multiple mediation approach Mismatch negativity tells you how much you automatically care for your...